[Kasabach-Merritt syndrome. Presentation of 2 cases: one treated with prednisone and the other with aminocaproic acid, prednisone and cobalt therapy].
Lobo-Sanahuja
F
F
Jiménez-Fonseca
E
E
García
I
I
Jiménez
R
R
D000614:Aminocaproates / Q000627:therapeutic use*; D001803:Blood Transfusion; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D005153:Facial Neoplasms / Q000151:congenital / Q000188:drug therapy* / Q000532:radiotherapy; D005260:Female; D006392:Hemangioma, Cavernous / Q000151:congenital / Q000188:drug therapy* / Q000532:radiotherapy; D006474:Hemorrhagic Disorders / Q000188:drug therapy* / Q000532:radiotherapy; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007866:Leg; D008297:Male; D011241:Prednisone / Q000627:therapeutic use*; D011867:Radioisotope Teletherapy; D013577:Syndrome; D013921:Thrombocytopenia / Q000188:drug therapy / Q000532:radiotherapy
D000614:Aminocaproates; D003037:Cobalt Radioisotopes; D011241:Prednisone
Síndrome de Kasabach-Merritt. Presentación de dos casos: uno tratado con prednisona y otro con ácido aminocaproico, prednisona y cobaltoterapia.